Skip to main content
TipRanks
Go Ultimate75% OFF

Andreas Maetzel Insider Profile

4 Followers

Andreas Maetzel, former VP, Clinical and Regulatory at Cornerstone Therapeutics Inc, holds 0.00 shares in KalVista Pharmaceuticals (Ticker: KALV), holds 0.00 shares in Cornerstone Therapeutics Inc (Ticker: ~CRTX).

Andreas Maetzel's Trading History

KALV
KalVista Pharmaceuticals
Apr 29, 2021―Uninformative Buy809.93K$0.00
~CRTX
Cornerstone Therapeutics Inc
Feb 04, 2014―Uninformative Sell237.50K―

You May Also Like

Andreas Maetzel insider profile FAQ

What is the percentage of profitable transactions made by Andreas Maetzel?
The percentage of profitable transactions made by Andreas Maetzel is 100%.
What is the average return per transaction made by Andreas Maetzel?
The average return per transaction made by Andreas Maetzel is 58.10%.
What stocks does Andreas Maetzel hold?
Andreas Maetzel holds: ~CRTX, KALV stocks.
What was Andreas Maetzel’s latest transaction?
Andreas Maetzel’s latest transaction was an Uninformative Buy of $809.93K.
What was Andreas Maetzel's most profitable transaction?
Andreas Maetzel’s most profitable transaction was an Informative Sell of KALV stock on April 9, 2019. The return on the trade was 66.70%.
What is Andreas Maetzel's role in Cornerstone Therapeutics Inc?
Andreas Maetzel's role in Cornerstone Therapeutics Inc is VP, Clinical and Regulatory.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.